Treatment
Piperacillin-tazobactam clinical trials
We’re tracking 9 recruiting studies that include Piperacillin-tazobactam, each written for real people, not researchers, below.
Recruiting studies
- NCT06426836Recruiting
Better antibiotic dosing for children on ECMO
This trial studies how to give the right dose of common antibiotics to children on ECMO (a heart-lung bypass machine). The goal is to help doctors choose the best dose to fight infections while keeping the child safe.
Brussels, Brussels CapitalAges Up to 15 years - NCT02456974Recruiting
Testing how antibiotics are dosed in children’s intensive care
This study looks at whether giving common antibiotics in certain dose schedules (either through a drip over time or continuously) is done in a way that fits pediatric intensive care needs. It may help improve antibiotic treatment for children who are very sick and need antibiotics.
GhentAges 1 day–16 years - NCT06293677RecruitingPhase 4
Antibiotic Dosing for Kids With Cancer and Fever
This study tests whether adjusting antibiotic doses based on how fast your kidneys clear the medicine can better treat infections in children with cancer who have a fever and low white blood cells (neutropenia). It aims to improve recovery and reduce side effects.
Lausanne, Canton of VaudAges 2 months–18 years - NCT06954129RecruitingPhase 4
Comparing two antibiotic combos for infection and kidney safety
This trial compares two common antibiotic combinations to see which one is less likely to cause kidney injury in hospitalized patients. You may be eligible if you need treatment with vancomycin plus either piperacillin-tazobactam or cefepime.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06972537Recruiting
Piperacillin-Tazobactam Dosing for Pneumonia in Older Adults
This study looks at the best way to give the antibiotic piperacillin-tazobactam (Zosyn) to people 65 and older who have pneumonia. It aims to make treatment more effective and safer for older adults.
Jinan, ShandongAges 65–100 - NCT05565222RecruitingPhase 3
Testing two antibiotics as alternatives for ICU severe ESBL infections
This study compares two antibiotics—piperacillin-tazobactam or temocillin—to treat severe ICU infections caused by certain hard-to-treat gut bacteria (ESBL). It may help patients avoid the use of carbapenem antibiotics like meropenem when the bacteria are susceptible.
ParisAges 18 years+ - NCT06712641RecruitingPhase 4
Testing aminoglycoside antibiotics for early sepsis
This trial tests a type of antibiotic called aminoglycosides to treat early sepsis (a serious infection). It is for adults in the hospital who are sick enough to need strong antibiotics but not in the worst stage of the illness.
Bergen, BergenAges 18 years+ - NCT02735707RecruitingPhase 3
Adaptive trial for severe pneumonia care in intensive care
This study tests ways to improve treatment for adults with severe pneumonia that lands them in the ICU, adjusting the plan as results come in. It may help your care team find better treatments for lung infection and breathing/heart support needs.
Jacksonville, FloridaAges 18 years+ - NCT07620223Recruiting
Antibiotics to prevent infection after liver surgery
This study tests whether giving antibiotics before liver or bile duct surgery can prevent wound infections in areas where bacteria are resistant to many antibiotics. You would receive antibiotics as a preventive measure and be monitored for any surgical site infections.
Nanjing, JiangsuAges 18 years+
What Piperacillin-tazobactam is being studied for
Conditions with recruiting Piperacillin-tazobactam studies.
Common questions
- Are there clinical trials studying Piperacillin-tazobactam?
- Yes. Clin2 currently lists 9 recruiting studies that include Piperacillin-tazobactam, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Piperacillin-tazobactam trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Piperacillin-tazobactam an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Piperacillin-tazobactam or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.